Cargando…
Changes in Wnt and TGF-β Signaling Mediate the Development of Regorafenib Resistance in Hepatocellular Carcinoma Cell Line HuH7
Hepatocellular carcinoma (HCC) is an aggressive, chemo resistant neoplasm with poor prognosis and limited treatment options. Exploring activated pathways upon drug treatment can be used to discover more effective anticancer agents to overcome therapy resistance and enhance therapeutic outcomes for p...
Autores principales: | Karabicici, Mustafa, Azbazdar, Yagmur, Ozhan, Gunes, Senturk, Serif, Firtina Karagonlar, Zeynep, Erdal, Esra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386122/ https://www.ncbi.nlm.nih.gov/pubmed/34458250 http://dx.doi.org/10.3389/fcell.2021.639779 |
Ejemplares similares
-
Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer
por: Azbazdar, Yagmur, et al.
Publicado: (2021) -
Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7
por: Karabicici, Mustafa, et al.
Publicado: (2021) -
Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic Diseases
por: Karabicici, Mustafa, et al.
Publicado: (2021) -
A Novel Function for KLF4 in Modulating the De-Differentiation of EpCAM(−)/CD133(−) nonStem Cells into EpCAM(+)/CD133(+) Liver Cancer Stem Cells in HCC Cell Line HuH7
por: Firtina Karagonlar, Zeynep, et al.
Publicado: (2020) -
Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β‐catenin signaling and tumor growth
por: Azbazdar, Yagmur, et al.
Publicado: (2023)